Saygin, C., Patel, A., Levavi, H., O’Dwyer, K., Long, M., Vargas Madueno, F., … Stock, W. (2025). Trial in progress: A Phase I/II study to investigate the combination of LP-118, ponatinib, vincristine and dexamethasone (LPVd regimen) in relapsed/refractory T-ALL/lbl. In Blood (Vol. 146, pp. 5136–5136). American Society of Hematology. https://doi.org/10.1182/blood-2025-5136

Saygin, Caner, Anand Patel, Hannah Levavi, Kristen O’Dwyer, Meixiao Long, Fernando Vargas Madueno, Chenyu Lin, et al. “Trial in progress: A Phase I/II study to investigate the combination of LP-118, ponatinib, vincristine and dexamethasone (LPVd regimen) in relapsed/refractory T-ALL/lbl.” In Blood, 146:5136–5136. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-5136.

Saygin C, Patel A, Levavi H, O’Dwyer K, Long M, Vargas Madueno F, et al. Trial in progress: A Phase I/II study to investigate the combination of LP-118, ponatinib, vincristine and dexamethasone (LPVd regimen) in relapsed/refractory T-ALL/lbl. In: Blood. American Society of Hematology; 2025. p. 5136–5136.

Saygin, Caner, et al. “Trial in progress: A Phase I/II study to investigate the combination of LP-118, ponatinib, vincristine and dexamethasone (LPVd regimen) in relapsed/refractory T-ALL/lbl.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 5136–5136. Crossref, doi:10.1182/blood-2025-5136.

Saygin C, Patel A, Levavi H, O’Dwyer K, Long M, Vargas Madueno F, Lin C, Karrison T, Weiner H, Duvall A, Kosuri S, Madero-Marroquin R, Roloff G, Drazer M, Thirman M, Larson R, Odenike O, Reddick LE, Chen Y, Anthony S, Stock W. Trial in progress: A Phase I/II study to investigate the combination of LP-118, ponatinib, vincristine and dexamethasone (LPVd regimen) in relapsed/refractory T-ALL/lbl. Blood. American Society of Hematology; 2025. p. 5136–5136.